Chelsea Therapeutics Internatio (CHTP)
Chelsea Therapeutics Internatio is related to 1 other symbol. To date we've encountered releases involving Chelsea Therapeutics Internatio.
Last Price: 1.70 (+0.08) - 1/7/2009,
3:59pm
- Open: 1.67
- High: 1.70
- Low: 1.59
Chelsea Therapeutics Internatio Options
- Chelsea Therapeutics Internatio "Business Partners"
- Chelsea Therapeutics Internatio Press Releases
- Chelsea Therapeutics Internatio News
- Chelsea Therapeutics Internatio Contact
- Chelsea Therapeutics Internatio Related (via TRYNT)
Chelsea Therapeutics Internatio "Business Partners"
A "business partner" is defined as a third party company that has co-released at least one press release with Chelsea Therapeutics Internatio.
Chelsea Therapeutics Internatio Press Releases
- We have not detected any press releases (via MarketWire) yet.
Chelsea Therapeutics Internatio News
- The January Effect in Small Caps: Screens (at Seeking Alpha), Sun, 14 Dec 2008 10:31:11 Etc/GMT
- Chelsea Therapeutics Completes Enrollment in Phase II Trial of Droxidopa in Intradialytic Hypotension (GlobeNewswire), Wed, 19 Nov 2008 12:30:00 Etc/GMT
- Chelsea Therapeutics Initiates Phase I Clinical Trial of CH-4051 (GlobeNewswire), Thu, 13 Nov 2008 12:30:00 Etc/GMT
- Chelsea Therapeutics to Host Analyst and Institutional Investor Day in New York (GlobeNewswire), Wed, 12 Nov 2008 12:30:00 Etc/GMT
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Financials (EDGAR Online Financials), Tue, 11 Nov 2008 14:04:25 Etc/GMT
- New Star Analyst Rankings for CHELSEA THERAPEUTICS (StarMine), Thu, 6 Nov 2008 14:25:45 Etc/GMT
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly Report (EDGAR Online), Thu, 6 Nov 2008 14:02:23 Etc/GMT
- Chelsea Therapeutics Reports Third Quarter 2008 Results (GlobeNewswire), Wed, 5 Nov 2008 12:30:00 Etc/GMT
- Q3 2008 CHELSEA THERAPEUTICS Earnings Release - Before Market Open (CCBN), Wed, 5 Nov 2008 12:07:09 Etc/GMT
- Chelsea Therapeutics Reports Significant Reduction in Severity of Symptoms During Titration Phase of Pivotal Droxidopa Study in Neurogenic Orthostatic Hypotension (GlobeNewswire), Mon, 3 Nov 2008 12:00:00 Etc/GMT
- Chelsea Therapeutics to Present At the Rodman and Renshaw 10th Annual Healthcare Conference On Monday, November 10, 2008 (GlobeNewswire), Thu, 30 Oct 2008 11:30:00 Etc/GMT
- Data From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 19th Annual International Symposium on the Autonomic Nervous System (GlobeNewswire), Wed, 29 Oct 2008 11:25:00 Etc/GMT
- Chelsea Therapeutics Completes Enrollment in Phase II Trial of CH-1504 in Rheumatoid Arthritis (GlobeNewswire), Tue, 28 Oct 2008 11:25:00 Etc/GMT
- Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2008 Results (GlobeNewswire), Mon, 27 Oct 2008 11:30:00 Etc/GMT
- Chelsea Therapeutics Announces Positive DSMB Recommendation for CH-1504 Phase II Trial in Rheumatoid Arthritis (GlobeNewswire), Tue, 21 Oct 2008 11:30:00 Etc/GMT
- Chelsea Therapeutics to Present At the Oppenheimer 19th Annual Healthcare Conference On Tuesday, November 4, 2008 (GlobeNewswire), Mon, 20 Oct 2008 12:25:27 Etc/GMT
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K/A, Regulation FD Disclosure (EDGAR Online), Fri, 10 Oct 2008 19:03:58 Etc/GMT
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online), Fri, 10 Oct 2008 14:45:51 Etc/GMT
- Chelsea Therapeutics to Present At the UBS Global Life Sciences Conference On Monday, September 22, 2008 (GlobeNewswire), Tue, 16 Sep 2008 11:30:00 Etc/GMT
- Chelsea Therapeutics Begins Patient Dosing in Second Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension (GlobeNewswire), Tue, 2 Sep 2008 11:30:00 Etc/GMT
Chelsea Therapeutics Internatio Contact
- We have not detected any contact information yet.
TRYNT Related
- TRYNT did not suggest any related symbols
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.